Do you want to get instant company alerts to the front screen of your smartphone? Download the Vox Markets app here: www.VoxMarkets.co.uk/app
Open Orphan is a rapidly growing niche CRO pharmaceutical services company which is a world leader in the provision of viral laboratory services and the testing of vaccine and antivirus using human challenge study models. Open Orphan comprises of two commercial specialist CRO services businesses; hVIVO and Venn Life Sciences, and Open Orphan Genomic Health Data.
(Interview starts at 10 minutes 43 seconds)
(Interview starts at 26 minutes 13 seconds)
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.
In a half year eport for the six month period to 31 March 2020, the group said it had met its initial objective in identifying and acquiring an early stage natural resources project which it believes holds “tremendous growth potential.”
The government is looking at ways to relax the 14-day quarantine rule for people entering the UK over coming months. As it stands from Monday, most people arriving by plane, ferry or train - including UK nationals - must self-isolate.